Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Host Directed Therapies for Pulmonary Tuberculosis
NCT02968927Phase 2Unknown
- Sponsor
- Aurum Institute
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of everolimus, auranofin, vitamin d and dovramilast in pulmonary tuberculosis (TB), sponsored by Aurum Institute. Status: unknown.
02
Drugs
everolimusauranofinvitamin ddovramilast
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02968927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968927.